# Hypertension: Conducting Studies of Drugs to Treat Patients on a Background of Multiple Antihypertensive Drugs Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/hypertension-conducting-studies-of-drugs-to-treat-patients-on-a-background-of-multiple-antihypertensive-drugs-guidance-for-industry/4e191c93-73a7-441d-880d-19605847d3b1

> FDA guidance document: Hypertension: Conducting Studies of Drugs to Treat Patients on a Background of Multiple Antihypertensive Drugs Guidance for Industry. Issue date: July 13, 2018. Get complete insights and analysis.

---

## Details

- Title: Hypertension: Conducting Studies of Drugs to Treat Patients on a Background of Multiple Antihypertensive Drugs Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-07-13
- Comment Close Date: 2018-10-12
- Last Changed: 2019-10-18
- Docket Number: <a href="https://www.regulations.gov/docket/ FDA-2018-D-2515"> FDA-2018-D-2515</a>

## Related Documents

- [Establishing Impurity Specifications for Antibiotics](https://www.globalkeysolutions.net/guidances/guidance-document/establishing-impurity-specifications-for-antibiotics/5bb8badb-7c32-4b76-bfc9-bbb8ab55fb84)
- [Data Integrity for In Vivo Bioavailability and Bioequivalence Studies](https://www.globalkeysolutions.net/guidances/guidance-document/data-integrity-for-in-vivo-bioavailability-and-bioequivalence-studies/04d979b3-3f1d-4515-b9c1-f1a8fb7fb19b)
- [Innovative Approaches for Nonprescription Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/innovative-approaches-for-nonprescription-drug-products/212b0dcc-7c8f-44f5-8fd2-1af604a50f9a)